Edition:
India

Akari Therapeutics PLC (AKTX.OQ)

AKTX.OQ on NASDAQ Stock Exchange Capital Market

2.19USD
18 Jun 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$2.19
Open
$2.21
Day's High
$2.21
Day's Low
$2.10
Volume
2,350
Avg. Vol
401,545
52-wk High
$9.19
52-wk Low
$1.56

About

Akari Therapeutics, Plc, formerly Celsus Therapeutics Plc, is a clinical-stage biopharmaceutical company. It is focused on the development and commercialization of treatments for a range of rare and orphan autoimmune and inflammatory diseases caused by dysregulation of complement component 5 (C5), including paroxysmal nocturnal... (more)

Overall

Beta: -8.40
Market Cap(Mil.): $71.13
Shares Outstanding(Mil.): 0.12
Dividend: --
Yield (%): --

Financials

Earnings vs. Estimates